Steward Partners Investment Advisory’s Akoya BioSciences AKYA Stock Holding History

Steward Partners Investment Advisory’s Portfolio AKYA Stock Details AKYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-400	Closed	-$916	–	4019
2024 Q4	$916	Hold	400	–	–	﹤0.01%	3771
2024 Q3	$1.09K	Hold	400	–	–	﹤0.01%	3523
2024 Q2	$936	Hold	400	–	–	﹤0.01%	3401
2024 Q1	$1.88K	Hold	400	–	–	﹤0.01%	3302
2023 Q4	$1.95K	Buy	+400	New	+$1.66K	﹤0.01%	3209

Other funds holding AKYA

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

BWLSA

Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAPAIJV

Paragon Associates & Paragon Associates II Joint Venture Dallas, Texas $73.6M AUM 61.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

PCA

Peddock Capital Advisors Braintree, Massachusetts $501M AUM 29.8% 1-Year Est. Return

Steward Partners Investment Advisory's AKYA Position: Q1 2025 in Review

Steward Partners Investment Advisory sold out of Akoya BioSciences (AKYA) in Q1 2025, closing a stake of 400 shares — an estimated $916 sold.

Steward Partners Investment Advisory first reported a position in AKYA in Q4 2023 and held it in 5 quarters. The position peaked at $1.95K in Q4 2023. 64 funds tracked by Wall St. Rank hold AKYA as of Q1 2025.

Steward Partners Investment Advisory reported no remaining Akoya BioSciences position as of Q1 2025 after selling out during the quarter.
Steward Partners Investment Advisory sold 400 Akoya BioSciences shares in Q1 2025, an estimated $916.
Steward Partners Investment Advisory first reported a position in Akoya BioSciences in Q4 2023 and held it in 5 quarters.
Steward Partners Investment Advisory's Akoya BioSciences position peaked at $1.95K in Q4 2023.
64 funds tracked by Wall St. Rank held Akoya BioSciences as of Q1 2025.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2025, filed 13 May 2025.